Literature DB >> 10496064

Severe aspiration pneumonia after surgery for reconstructed gastric tube cancer treated with extracorporeal life support.

S Motoyama1, M Kitamura, S Kamata, H Suzuki, S Sekine, J Ogawa.   

Abstract

A 68-year-old man who had received resection for thoracic esophageal cancer 8 years ago, was operated on for the cancer of the reconstructed gastric tube. On the day of the operation, he accidentally swallowed gastric juice due to an obstruction in the reconstructed gastric tube. He suffered from acute hypoxic respiratory failure which could not be controlled with conventional therapy on postoperative day 1. Therefore, extracorporeal life support was employed at 3.0 L/min. extracorporeal flow for 11 days. Before extracorporeal life support data: PO2/FiO2 = 45, A-aDO2 = 600. During extracorporeal life support, the ventilator setting was pressure control (16 cmH2O) ventilation with a positive end expiratory pressure of 8 cmH2O, respiratory rate of 5 breaths/min., and FiO2 of 0.4. The patient was successfully weaned from extracorporeal life support and extubated on postoperative day 12. After extracorporeal life support data: PO2/FiO2 = 225, A-aDO2 = 465. We report on a successful weaning case from extracorporeal life support and discuss the efficacy these of regarding this patient.

Entities:  

Mesh:

Year:  1999        PMID: 10496064     DOI: 10.1007/BF03218032

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  6 in total

1.  Prolonged paralysis after treatment with neuromuscular junction blocking agents.

Authors:  J L Gooch; M R Suchyta; J M Balbierz; J H Petajan; T P Clemmer
Journal:  Crit Care Med       Date:  1991-09       Impact factor: 7.598

2.  Mortality is directly related to the duration of mechanical ventilation before the initiation of extracorporeal life support for severe respiratory failure.

Authors:  T Pranikoff; R B Hirschl; C N Steimle; H L Anderson; R H Bartlett
Journal:  Crit Care Med       Date:  1997-01       Impact factor: 7.598

3.  Extracorporeal life support for 100 adult patients with severe respiratory failure.

Authors:  S Kolla; S S Awad; P B Rich; R J Schreiner; R B Hirschl; R H Bartlett
Journal:  Ann Surg       Date:  1997-10       Impact factor: 12.969

4.  Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study.

Authors:  W M Zapol; M T Snider; J D Hill; R J Fallat; R H Bartlett; L H Edmunds; A H Morris; E C Peirce; A N Thomas; H J Proctor; P A Drinker; P C Pratt; A Bagniewski; R G Miller
Journal:  JAMA       Date:  1979-11-16       Impact factor: 56.272

5.  High-frequency oscillatory ventilation and extracorporeal membrane oxygenation for the treatment of acute neonatal respiratory failure.

Authors:  J M Carter; D R Gerstmann; R H Clark; G Snyder; J D Cornish; D M Null; R A deLemos
Journal:  Pediatrics       Date:  1990-02       Impact factor: 7.124

6.  Emergent applications of cardiopulmonary support: a multiinstitutional experience.

Authors:  J G Hill; P S Bruhn; S E Cohen; M W Gallagher; F Manart; C A Moore; P E Seifert; P Askari; C Banchieri
Journal:  Ann Thorac Surg       Date:  1992-10       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.